Linnea Cipriano is a partner in Goodwin's Intellectual Property Litigation group. Her practice focuses on patent litigation in federal courts and the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB).
Ms. Cipriano has particular expertise in litigation and counseling in the pharmaceutical industry, including preparing for and representing clients in district court litigation under the Hatch-Waxman Act and BPCIA. Ms. Cipriano’s experience extends to patents in the broader life science industry, including nutritional supplements, chemical manufacturing, DNA-based technology, medical devices, and drug delivery technologies.
Ms. Cipriano also focuses her practice on post grant proceedings at the PTAB and has represented clients in both inter partes review (IPR) and post grant review (PGR) proceedings. Ms. Cipriano has represented petitioners and patent owner’s in a wide variety of technologies, including pharmaceutical formulations, electronic devices, manufacturing methods, and medical devices.
Ms. Cipriano’s practice combines her in-depth knowledge of patent law with her scientific experience to serve her clients. She holds a graduate degree in pharmacology, and before pursuing a career in law, performed research at the Cleveland Clinic.
Representative matters include:
Ms. Cipriano’s pro bono work includes:
Prior to joining Goodwin, Ms. Cipriano was an associate in the New York office of Kenyon & Kenyon. She also worked as a legal intern at Cleveland Clinic Innovations and as a research technologist at the Cleveland Clinic Foundation.
Ms. Cipriano is a co-chair of NYIPLA’s Women in IP Law committee and is a member of the ChIPs Network.Ms. Cipriano was a 2021 recommended lawyer for Patent litigation: full coverage by The Legal 500.
Ms. Cipriano was selected to the Super Lawyers New York Metro Rising Stars list in 2015-2021.
Ms. Cipriano is the managing editor of the Goodwin PTAB Trial Tracker periodic newsletter.
“3 Best Practices For Patent Claims Against Secret Methods,” Law360 (co-authored, August 12, 2019)
Contributor, Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed., published by Thomson Reuters, November 2019
magna cum laude, Order of the Coif
cum laude
Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。